1,254 件 ・ 関連度順
概要と使いどころ
Determines whether an adult patient meets eligibility criteria for initiating gender-affirming hormone therapy. Triggered when an adult patient requests gender-affirming hormones or presents for evaluation of hormone therapy eligibility.
日本語の概要は準備中です。原文の説明を表示しています。
This skill recommends urgent treatment (within 24–72 hours) of hypercortisolism when life‑threatening complications of Cushing's syndrome such as infection, pulmonary thromboembolism, cardiovascular events, or acute psychosis are present. Trigger phrases include sepsis, PE, chest pain with hemodynamic instability, new‑onset psychosis, or delirium in a patient with known or suspected Cushing's.
日本語の概要は準備中です。原文の説明を表示しています。
This skill recommends against initiating treatments aimed at normalizing cortisol or its action when only borderline biochemical abnormalities of the hypothalamic-pituitary-adrenal (HPA) axis are present without specific signs of Cushing's syndrome. Use when encountering borderline urinary free cortisol, late-night salivary cortisol, or dexamethasone suppression test results without classic Cushingoid features; triggers include borderline UFC (1-2× ULN), equivocal late-night salivary cortisol, or nondiagnostic low-dose DST.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends potassium supplementation for hypokalemia management in PA patients who are pregnant or planning pregnancy. Triggered when a pregnant PA patient presents with low serum potassium and asks 'How should I treat hypokalemia?' or when electrolytes are reviewed.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends antihypertensive therapy including mineralocorticoid receptor antagonists (MRAs) for patients with a positive primary aldosteronism (PA) screening test who decline confirmatory testing. Triggers include when a patient has positive screening but refuses additional tests and asks "What should I treat with?" or initiates empiric therapy, with preference for MRAs in typical PA presentations (e.g., spontaneous hypokalemia, resistant hypertension, adrenal tumor on CT).
日本語の概要は準備中です。原文の説明を表示しています。
Suggests using morning cortisol ≤140 nmol/L (5 µg/dL) in combination with ACTH as a preliminary test suggestive of primary adrenal insufficiency when a corticotropin stimulation test is not feasible. Use when patients present with indicative symptoms such as hypotension, hyponatremia, hyperkalemia, or fatigue and corticotropin stimulation testing cannot be performed.
日本語の概要は準備中です。原文の説明を表示しています。
Suggests genetic counseling for patients with primary adrenal insufficiency (PAI) when a monogenic disorder is suspected. Use when PAI patient presents with early-onset disease, syndromic features, consanguinity, family history, or negative autoimmune antibodies.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends initiating fludrocortisone 50–100 µg daily for mineralocorticoid replacement in adults with confirmed aldosterone deficiency (e.g., low aldosterone, elevated renin) and no salt restriction. Use when aldosterone deficiency is confirmed in a patient with primary adrenal insufficiency (PAI) presenting with salt craving or postural hypotension.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends immediate IV hydrocortisone stress dosing for patients with suspected adrenal crisis presenting with severe adrenal insufficiency symptoms such as hypotension, hyponatremia, hyperkalemia, or acute abdominal pain. Use when clinician observes signs of adrenal crisis (e.g., syncope, delirium, marked abdominal tenderness) prior to diagnostic test results.
日本語の概要は準備中です。原文の説明を表示しています。
This skill outlines the emergency management of suspected adrenal crisis, recommending immediate parenteral hydrocortisone (100 mg adult, 50 mg/m² pediatric) plus fluid resuscitation, then 200 mg/24 h (50–100 mg/m²/24 h pediatric) hydrocortisone. Trigger when patient presents with hypotension, hyponatremia, hyperkalemia, or unexplained shock suggestive of adrenal insufficiency.
日本語の概要は準備中です。原文の説明を表示しています。
Suggests a trial of dehydroepiandrosterone (DHEA) replacement in women with primary adrenal insufficiency (PAI) who report low libido, depressive symptoms, and/or low energy levels despite otherwise optimized glucocorticoid and mineralocorticoid replacement. Consider when a woman with PAI presents with persistent low libido, depressive symptoms, and/or low energy levels after glucocorticoid and mineralocorticoid doses have been titrated to clinical targets.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends confirmatory testing with corticotropin stimulation test in patients presenting with clinical symptoms or signs suggesting PAI (e.g., fatigue, hypotension, hyponatremia, hyperpigmentation) when the patient's condition permits safe testing. Use when a clinician identifies suggestive features and circumstances allow outpatient stimulation testing without imminent need for emergency glucocorticoids.
日本語の概要は準備中です。原文の説明を表示しています。
Recommends diagnostic testing to exclude primary adrenal insufficiency (PAI) in acutely ill patients presenting with otherwise unexplained volume depletion, hypotension, hyponatremia, hyperkalemia, fever, abdominal pain, hyperpigmentation, or hypoglycemia (especially in children). Use when clinical suspicion arises from these suggestive signs or symptoms suggestive of PAI.
日本語の概要は準備中です。原文の説明を表示しています。
Traceability review — every spec AC must trace to a resolvable upstream AC in the intake (and BRD if present), and no upstream AC is silently dropped. Read-only. Run alongside `spec-diagram-review` before implementation.
日本語の概要は準備中です。原文の説明を表示しています。
Split a dirty working tree into single-concern Conventional Commits. The deterministic inventory.mjs helper groups dirty paths by concern (docs, source + paired test, config, governance); main context refines the grouping and presents a commit plan. Read-only until the user approves the plan — it never stages, never commits, never touches consent paths. Disjoint from the commit skill (Phase 11 executor): the planner proposes a split; the executor lands one consented commit. Use when a working tree has accumulated heterogeneous changes that should not land as one commit.
日本語の概要は準備中です。原文の説明を表示しています。
Detects when Claude is uncertain but presenting answers confidently. Teaches Claude to recognize and communicate uncertainty clearly instead of masking it with confident language.
日本語の概要は準備中です。原文の説明を表示しています。
Generate conservative, editable English outreach drafts for foreign-trade sales from structured lead inputs and customer-intel signals. Use when an operator needs a first-touch or follow-up email draft that calls confirmed recent/customer-market signals from the customer-intel Skill, with subject options, review notes, and explicit reminders not to present unconfirmed facts as facts.
日本語の概要は準備中です。原文の説明を表示しています。
Use when implementation is complete, all tests pass, and you need to decide how to integrate the work - guides completion of development work by presenting structured options for merge, PR, or cleanup
日本語の概要は準備中です。原文の説明を表示しています。
Expert-level compiler design covering lexical analysis, parsing, semantic analysis, intermediate representations, optimization passes, and code generation.
日本語の概要は準備中です。原文の説明を表示しています。
Use when implementation is complete and you need to decide how to integrate the work — presents structured options for merge, PR, keep, or discard
日本語の概要は準備中です。原文の説明を表示しています。
Scan a codebase for deepening opportunities, present them as a visual HTML report, then grill through whichever one you pick.
日本語の概要は準備中です。原文の説明を表示しています。
Use for every progress update, status report, problem explanation, ETA, review, acceptance, or completion report to the operator/owner, especially when they ask “到哪了”, “什么问题”, “做了什么”, “结果呢”, “还要多久”, or “说人话”. Translate technical evidence into visible or operational outcomes before details.
日本語の概要は準備中です。原文の説明を表示しています。
视觉演示工坊——用HTML做高保真原型、幻灯片、动画、可视化与专家评审，需求模糊时给设计方向。触发词：做原型、PPT、幻灯片、动画、设计风格、评审、做个HTML页面、UI mockup、导出MP4/GIF、做个好看的。生产级Web App/需后端的系统不适用。
日本語の概要は準備中です。原文の説明を表示しています。
Enforce traceability from natural-language intent to machine predicates, final observables, evidence, and owner-readable acceptance. Use when conducting any audit, review, QA pass, parity or compliance check, security assessment, code or architecture review, visual or behavioral comparison, data validation, system verification, completion gate, or claim that an implementation satisfies a human request.
日本語の概要は準備中です。原文の説明を表示しています。